186 related articles for article (PubMed ID: 29258455)
21. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
22. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
[TBL] [Abstract][Full Text] [Related]
23. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
24. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies.
Edeza A; Karina Santamaria E; Valente PK; Gomez A; Ogunbajo A; Biello K
AIDS Care; 2021 Jun; 33(6):697-705. PubMed ID: 32530302
[TBL] [Abstract][Full Text] [Related]
25. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
Hartmann M; Nyblade L; Otticha S; Marton T; Agot K; Roberts ST
J Int AIDS Soc; 2024 Feb; 27(2):e26213. PubMed ID: 38379129
[TBL] [Abstract][Full Text] [Related]
26. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis.
Wettstein C; Mugglin C; Egger M; Blaser N; Vizcaya LS; Estill J; Bender N; Davies MA; Wandeler G; Keiser O;
AIDS; 2012 Nov; 26(18):2361-73. PubMed ID: 22948267
[TBL] [Abstract][Full Text] [Related]
27. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
[TBL] [Abstract][Full Text] [Related]
28. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
[TBL] [Abstract][Full Text] [Related]
29. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.
Golub SA; Gamarel KE; Rendina HJ; Surace A; Lelutiu-Weinberger CL
AIDS Patient Care STDS; 2013 Apr; 27(4):248-54. PubMed ID: 23565928
[TBL] [Abstract][Full Text] [Related]
30. Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review.
Nalubega S; Evans C
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):330-420. PubMed ID: 26455613
[TBL] [Abstract][Full Text] [Related]
31. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
[TBL] [Abstract][Full Text] [Related]
32. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.
Galindo GR; Garrett-Walker JJ; Hazelton P; Lane T; Steward WT; Morin SF; Arnold EA
Implement Sci; 2012 Nov; 7():116. PubMed ID: 23181780
[TBL] [Abstract][Full Text] [Related]
33. Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?
Stankevitz K; Schwartz K; Hoke T; Li Y; Lanham M; Mahaka I; Mullick S
PLoS One; 2019; 14(6):e0218556. PubMed ID: 31226165
[TBL] [Abstract][Full Text] [Related]
34. Motivations for pre-exposure prophylaxis uptake and decline in an HIV-hyperendemic setting: findings from a qualitative implementation study in Lesotho.
Chebet JJ; McMahon SA; Tarumbiswa T; Hlalele H; Maponga C; Mandara E; Ernst K; Alaofe H; Baernighausen T; Ehiri JE; Geldsetzer P; Nichter M
AIDS Res Ther; 2023 Jul; 20(1):43. PubMed ID: 37415180
[TBL] [Abstract][Full Text] [Related]
35. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
36. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
37. Using a Multi-level Framework to Test Empirical Relationships Among HIV/AIDS-Related Stigma, Health Service Barriers, and HIV Outcomes in KwaZulu-Natal, South Africa.
Williams LD; Aber JL;
AIDS Behav; 2020 Jan; 24(1):81-94. PubMed ID: 30798458
[TBL] [Abstract][Full Text] [Related]
38. Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward.
Torres-Rueda S; Terris-Prestholt F; Gafos M; Indravudh PP; Giddings R; Bozzani F; Quaife M; Ghazaryan L; Mann C; Osborne C; Kavanagh M; Godfrey-Faussett P; Medley G; Malhotra S
Pharmacoeconomics; 2023 Jul; 41(7):787-802. PubMed ID: 36905570
[TBL] [Abstract][Full Text] [Related]
39. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
[TBL] [Abstract][Full Text] [Related]
40. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
